title: The medial preoptic nucleus integrates the central influences of testosterone on the paraventricular nucleus of the hypothalamus and its extended circuitries.
abstract: Testosterone contributes to sex differences in hypothalamic-pituitary-adrenal (HPA) function in humans and rodents, but the central organization of this regulation remains unclear. The medial preoptic nucleus (MPN) stands out as an important candidate in this regard because it contains androgen receptors and projects to forebrain nuclei integrating cognitive-affective information and regulating HPA responses to homeostatic threat. These include the HPA effector neurons of the paraventricular nucleus (PVN) of the hypothalamus, medial amygdala, and lateral septum. To test the extent to which androgen receptors in the MPN engage these cell groups, we compared in adult male rats the effects of unilateral microimplants of testosterone and the androgen receptor antagonist hydroxyflutamide into the MPN on acute restraint induced activation and/or neuropeptide expression levels. The basic effects of these implants were lateralized to the sides of the nuclei ipsilateral to the implants. Testosterone, but not hydroxyflutamide implants, decreased stress-induced Fos and arginine vasopressin (AVP) heteronuclear RNA expression in the PVN, as well as Fos expression in the lateral septum. In unstressed animals, AVP mRNA expression in the PVN decreased and increased in response to testosterone and hydroxflutamide MPN implants, respectively. The differential influences of these implants on AVP mRNA expression were opposite in the medial amygdala. These results confirm a role for androgen receptors in the MPN to concurrently modulate neuropeptide expression and activational responses in the PVN and its extended circuitries. This suggests that the MPN is capable of bridging converging limbic influences to the HPA axis with changes in gonadal status.
authors.affiliation: Neuroscience Program, Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Martin
authors.initials: M
authors.lastname: Williamson
authors.forename: Brenda
authors.initials: B
authors.lastname: Bingham
authors.forename: Megan
authors.initials: M
authors.lastname: Gray
authors.forename: Leyla
authors.initials: L
authors.lastname: Innala
authors.forename: Victor
authors.initials: V
authors.lastname: Viau
mesh_terms: D000728:Androgens; D000818:Animals; D004343:Drug Implants; D007276:Injections, Intraventricular; D008297:Male; D009415:Nerve Net / Q000187:drug effects / Q000378:metabolism*; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects* / Q000502:physiology*; D011301:Preoptic Area / Q000187:drug effects* / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011944:Receptors, Androgen / Q000378:metabolism; D013739:Testosterone / Q000008:administration & dosage / Q000097:blood / Q000502:physiology*
chemical_list: D000728:Androgens; D004343:Drug Implants; D011944:Receptors, Androgen; D013739:Testosterone
references.citation: Nat Rev Neurosci. 2009 Jun;10(6):459-66
references.pmid: 19339973
references.citation: J Comp Neurol. 2001 Aug 6;436(4):430-55
references.pmid: 11447588
references.citation: Endocrinology. 2003 Jul;144(7):3067-75
references.pmid: 12810563
references.citation: J Comp Neurol. 1986 Apr 15;246(3):312-42
references.pmid: 3517086
references.citation: Prog Brain Res. 2000;126:117-32
references.pmid: 11105644
references.citation: Psychoneuroendocrinology. 2006 Jun;31(5):642-52
references.pmid: 16616815
references.citation: J Neuroendocrinol. 2010 Feb;22(2):92-101
references.pmid: 20002965
references.citation: J Neuroendocrinol. 2001 May;13(5):442-52
references.pmid: 11328455
references.citation: J Comp Neurol. 2007 Aug 20;503(6):717-40
references.pmid: 17570493
references.citation: Cell Tissue Res. 1990 Jul;261(1):17-23
references.pmid: 2383883
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1239-48
references.pmid: 16214282
references.citation: J Comp Neurol. 2007 Jan 20;500(3):557-73
references.pmid: 17120292
references.citation: J Comp Neurol. 1993 Jun 1;332(1):123-43
references.pmid: 7685780
references.citation: Endocrinology. 2004 Jan;145(1):59-70
references.pmid: 14563697
references.citation: J Comp Neurol. 2006 Dec 20;499(6):911-23
references.pmid: 17072840
references.citation: J Neurosci. 1999 Aug 1;19(15):6684-93
references.pmid: 10414997
references.citation: Prog Brain Res. 1998;119:3-20
references.pmid: 10074777
references.citation: Neuroscience. 2006;138(3):947-55
references.pmid: 16310321
references.citation: Neurosci Lett. 1996 Oct 18;217(2-3):101-4
references.pmid: 8916082
references.citation: J Neuroendocrinol. 1994 Aug;6(4):433-42
references.pmid: 7987374
references.citation: Eur J Neurosci. 2005 Oct;22(7):1679-90
references.pmid: 16197508
references.citation: Brain Res. 1978 May 12;146(2):325-40
references.pmid: 647393
references.citation: J Neuroendocrinol. 1995 Nov;7(11):827-31
references.pmid: 8748118
references.citation: Eur J Neurosci. 1999 Jul;11(7):2312-22
references.pmid: 10383620
references.citation: Am J Physiol Regul Integr Comp Physiol. 2008 Oct;295(4):R1020-30
references.pmid: 18685071
references.citation: J Comp Neurol. 1988 Apr 8;270(2):209-42
references.pmid: 3259955
references.citation: Endocrinology. 2005 Jan;146(1):137-46
references.pmid: 15375029
references.citation: Endocrinology. 1987 Jul;121(1):233-40
references.pmid: 3496208
references.citation: Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):150-76
references.pmid: 15589267
references.citation: J Comp Neurol. 1986 Apr 15;246(3):343-63
references.pmid: 2422228
references.citation: Brain Res Bull. 1985 Mar;14(3):261-72
references.pmid: 3995367
references.citation: Mol Endocrinol. 1991 Oct;5(10):1447-56
references.pmid: 1775130
references.citation: J Neurosci. 1996 Jan;16(1):262-73
references.pmid: 8613792
references.citation: J Comp Neurol. 1997 Dec 1;388(4):507-25
references.pmid: 9388012
references.citation: Biol Psychol. 2005 Apr;69(1):113-32
references.pmid: 15740829
references.citation: J Neurosci. 1993 Dec;13(12):5126-38
references.pmid: 8254363
references.citation: Front Neuroendocrinol. 1994 Dec;15(4):321-50
references.pmid: 7895891
references.citation: J Comp Neurol. 1980 Dec 1;194(3):555-70
references.pmid: 7451682
references.citation: J Comp Neurol. 2006 Jan 1;494(1):142-78
references.pmid: 16304685
references.citation: Ann N Y Acad Sci. 1994 Nov 14;743:95-120
references.pmid: 7802421
references.citation: Brain Res Brain Res Rev. 2001 Dec;38(1-2):192-246
references.pmid: 11750933
references.citation: J Comp Neurol. 2002 May 20;447(1):1-7
references.pmid: 11967890
references.citation: J Comp Neurol. 1998 Apr 6;393(2):244-66
references.pmid: 9548700
references.citation: J Neurosci. 2002 Feb 1;22(3):959-69
references.pmid: 11826124
references.citation: J Comp Neurol. 2004 Jan 6;468(2):277-98
references.pmid: 14648685
references.citation: Brain Res Brain Res Rev. 1997 Sep 19;24(2-3):115-95
references.pmid: 9385454
references.citation: Mol Endocrinol. 1992 Jul;6(7):1061-9
references.pmid: 1324419
references.citation: J Neurosci. 2007 Feb 21;27(8):2025-34
references.pmid: 17314298
references.citation: J Comp Neurol. 1995 Sep 18;360(2):213-45
references.pmid: 8522644
references.citation: J Neurosci. 2006 Feb 1;26(5):1448-56
references.pmid: 16452668
references.citation: J Comp Neurol. 1990 Apr 1;294(1):76-95
references.pmid: 2324335
references.citation: Brain Res. 1985 Jan 28;325(1-2):391-4
references.pmid: 3978433
references.citation: J Comp Neurol. 2002 Apr 15;445(4):293-307
references.pmid: 11920708